NexImmune (NEXI) Stock Chart & Stock Price History $0.23 -0.04 (-14.77%) (As of 12/20/2024 04:04 PM ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NexImmune Stock Price Performance 5 Day Performance0.00%1 Month Performance-37.55%3 Month Performance-7.20%6 Month Performance-91.92%Year-To-Date Performance-89.55%1 Year Performance-90.04% Receive NEXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.Click Here to get the full details about Crypto’s Hidden Gem NEXI Stock Chart for Sunday, December, 22, 2024 NEXI Chart by TradingView NexImmune Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/20/2024$0.27$0.23-14.77%$0.27$0.235,363 shs$322,000.0012/19/2024$0.23$0.27+17.33%$0.27$0.233,356 shs$378,000.0012/18/2024$0.23$0.23$0.25$0.2310,788 shs$322,000.0012/17/2024$0.30$0.23-22.67%$0.25$0.231,168 shs$324,000.0012/16/2024$0.23$0.30+30.43%$0.38$0.231,992 shs$418,000.0012/13/2024$0.23$0.23-0.09%$0.23$0.231,761 shs$320,000.00 Get the Latest News and Ratings for NEXI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. 12/12/2024$0.25$0.23-8.53%$0.41$0.23944 shs$321,000.0012/11/2024$0.23$0.25+9.37%$0.25$0.23723 shs$351,000.0012/10/2024$0.26$0.23-12.84%$0.28$0.233,159 shs$321,000.0012/09/2024$0.23$0.26+14.73%$0.26$0.233,405 shs$367,000.0012/06/2024$0.23$0.23$0.29$0.23515 shs$321,000.0012/05/2024$0.30$0.23-24.31%$0.23$0.233,536 shs$320,000.0012/04/2024$0.30$0.30+1.33%$0.30$0.235,614 shs$423,000.0012/03/2024$0.41$0.30-26.81%$0.32$0.305,422 shs$417,000.0012/02/2024$0.41$0.41-0.02%$0.41$0.301,540 shs$572,000.0011/29/2024$0.41$0.41$0.41$0.4195 shs$570,000.0011/28/2024$0.41$0.41$0.41$0.224,133 shs$570,000.0011/27/2024$0.30$0.41+36.67%$0.41$0.224,133 shs$570,000.0011/26/2024$0.30$0.30$0.33$0.3010,426 shs$417,000.0011/25/2024$0.35$0.30-14.29%$0.33$0.3010,426 shs$417,000.0011/22/2024$0.24$0.37+52.96%$0.40$0.304,008 shs$516,000.0011/21/2024$0.24$0.24+1.20%$0.24$0.222,796 shs$338,000.00 Related Companies Psyence Biomedical Stock Chart CohBar Stock Chart Oncternal Therapeutics Stock Chart Galera Therapeutics Stock Chart Eterna Therapeutics Stock Chart China SXT Pharmaceuticals Stock Chart Panbela Therapeutics Stock Chart Revelation Biosciences Stock Chart Kiromic BioPharma Stock Chart Altamira Therapeutics Stock Chart Receive NEXI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NexImmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NEXI) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexImmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexImmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
